Anne M. Delany

5.3k total citations
68 papers, 4.2k citations indexed

About

Anne M. Delany is a scholar working on Molecular Biology, Cancer Research and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Anne M. Delany has authored 68 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 25 papers in Cancer Research and 15 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Anne M. Delany's work include Bone Metabolism and Diseases (37 papers), MicroRNA in disease regulation (16 papers) and Bone health and treatments (13 papers). Anne M. Delany is often cited by papers focused on Bone Metabolism and Diseases (37 papers), MicroRNA in disease regulation (16 papers) and Bone health and treatments (13 papers). Anne M. Delany collaborates with scholars based in United States, United Kingdom and Germany. Anne M. Delany's co-authors include Ernesto Canalis, Kristina Kapinas, Catherine B. Kessler, Sheila Rydziel, Renata C. Pereira, Gloria Gronowicz, Constance Brinckerhoff, Rosa Maria Rodrigues Pereira, Michael Amling and Deena Durant and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Anne M. Delany

66 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne M. Delany United States 36 2.5k 1.3k 943 737 681 68 4.2k
Ryan C. Riddle United States 35 2.1k 0.8× 663 0.5× 734 0.8× 412 0.6× 836 1.2× 65 4.4k
Baruch Frenkel United States 41 3.1k 1.2× 611 0.5× 1.2k 1.3× 371 0.5× 522 0.8× 89 4.9k
Andrea Del Fattore Italy 30 2.2k 0.9× 578 0.5× 970 1.0× 362 0.5× 589 0.9× 74 3.7k
Michael W. Starbuck United States 19 3.2k 1.3× 423 0.3× 1.2k 1.3× 498 0.7× 611 0.9× 24 4.8k
Ryoko Okamoto United States 20 3.8k 1.5× 745 0.6× 1.5k 1.6× 806 1.1× 374 0.5× 33 5.4k
Thomas A. Linkhart United States 40 3.2k 1.3× 648 0.5× 992 1.1× 423 0.6× 708 1.0× 80 5.1k
A. J. Kahn United States 30 2.9k 1.1× 523 0.4× 1.1k 1.2× 699 0.9× 385 0.6× 52 5.1k
Yuuki Imai Japan 32 2.5k 1.0× 511 0.4× 1.1k 1.1× 373 0.5× 500 0.7× 125 4.0k
Sutada Lotinun United States 32 2.2k 0.9× 361 0.3× 993 1.1× 338 0.5× 849 1.2× 70 3.8k

Countries citing papers authored by Anne M. Delany

Since Specialization
Citations

This map shows the geographic impact of Anne M. Delany's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne M. Delany with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne M. Delany more than expected).

Fields of papers citing papers by Anne M. Delany

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne M. Delany. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne M. Delany. The network helps show where Anne M. Delany may publish in the future.

Co-authorship network of co-authors of Anne M. Delany

This figure shows the co-authorship network connecting the top 25 collaborators of Anne M. Delany. A scholar is included among the top collaborators of Anne M. Delany based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne M. Delany. Anne M. Delany is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thakore, Pratish, et al.. (2025). Decreasing miR-433-3p Activity in the Osteoblast Lineage Blunts Glucocorticoid-mediated Bone Loss. Endocrinology. 166(2). 2 indexed citations
2.
Kim, Adam, et al.. (2025). Effects of aging on the immune and periosteal response to fracture injury. Bone. 198. 117524–117524.
3.
Thakore, Pratish, et al.. (2025). miR-433 targets BMP and Indian hedgehog signaling to coordinate murine postnatal growth plate dynamics. Journal of Bone and Mineral Research.
4.
Thakore, Pratish & Anne M. Delany. (2025). miRNA-based regulation in growth plate cartilage: mechanisms, targets, and therapeutic potential. Frontiers in Endocrinology. 16. 1530374–1530374. 2 indexed citations
5.
Lee, Sun‐Kyeong, et al.. (2024). The miR‐29‐3p family suppresses inflammatory osteolysis. Journal of Cellular Physiology. 239(8). e31299–e31299. 5 indexed citations
6.
7.
Drissi, Hicham, et al.. (2020). miR-433-3p suppresses bone formation and mRNAs critical for osteoblast function in mice. Journal of Bone and Mineral Research. 36(9). 1808–1822. 16 indexed citations
9.
Dole, Neha S., et al.. (2016). MicroRNA-433 Dampens Glucocorticoid Receptor Signaling, Impacting Circadian Rhythm and Osteoblastic Gene Expression. Journal of Biological Chemistry. 291(41). 21717–21728. 40 indexed citations
11.
Kapinas, Kristina, Katie M. Lowther, Catherine B. Kessler, et al.. (2012). Bone matrix osteonectin limits prostate cancer cell growth and survival. Matrix Biology. 31(5). 299–307. 26 indexed citations
12.
Kapinas, Kristina & Anne M. Delany. (2011). MicroRNA biogenesis and regulation of bone remodeling. Arthritis Research & Therapy. 13(3). 220–220. 142 indexed citations
13.
Kawai, Masanobu, Anne M. Delany, Carla B. Green, Martin L. Adamo, & Clifford J. Rosen. (2010). Nocturnin Suppresses Igf1 Expression in Bone by Targeting the 3′ Untranslated Region of Igf1 mRNA. Endocrinology. 151(10). 4861–4870. 37 indexed citations
14.
Kapinas, Kristina, Catherine B. Kessler, & Anne M. Delany. (2009). miR‐29 suppression of osteonectin in osteoblasts: Regulation during differentiation and by canonical Wnt signaling. Journal of Cellular Biochemistry. 108(1). 216–224. 213 indexed citations
15.
Kessler, Catherine B. & Anne M. Delany. (2007). Increased Notch 1 Expression and Attenuated Stimulatory G Protein Coupling to Adenylyl Cyclase in Osteonectin-Null Osteoblasts. Endocrinology. 148(4). 1666–1674. 25 indexed citations
16.
Pereira, Renata C., Anne M. Delany, & Ernesto Canalis. (2003). CCAAT/Enhancer Binding Protein Homologous Protein (DDIT3) Induces Osteoblastic Cell Differentiation. Endocrinology. 145(4). 1952–1960. 76 indexed citations
17.
Delany, Anne M., Ivo Kalajzić, Amy D. Bradshaw, E. Helene Sage, & Ernesto Canalis. (2003). Osteonectin-Null Mutation Compromises Osteoblast Formation, Maturation, and Survival. Endocrinology. 144(6). 2588–2596. 135 indexed citations
18.
Delany, Anne M.. (2001). Glucocorticoid Suppression of IGF I Transcription in Osteoblasts. Molecular Endocrinology. 15(10). 1781–1789. 29 indexed citations
19.
Delany, Anne M., Deena Durant, & Ernesto Canalis. (2001). Glucocorticoid Suppression of IGF I Transcription in Osteoblasts. Molecular Endocrinology. 15(10). 1781–1789. 115 indexed citations
20.
Delany, Anne M. & Constance Brinckerhoff. (1993). The synthetic retinoid (4‐hydroxyphenyl)retinamide decreases collagen expression in vitro and in the tight‐skin mouse. Arthritis & Rheumatism. 36(7). 983–993. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026